Mengya Wang obtained her MS degree from the University of Kansas in May 2016 and completed her PhD at the University of Iowa in May 2022. In December 2022, she joined Dr. Brennan's lab as a postdoctoral researcher. During her MS studies, Mengya conducted research on the modulation of the serotonin 1A receptor in depression. For her doctoral project, she delved into the mechanisms underlying migraine, employing techniques including microinjection, optogenetics, and a variety of animal behavioral assays. Her research highlighted the potential involvement of the cerebellum in migraine symptoms. Mengya's primary goal is to decipher the underlying mechanisms of migraine and develop novel therapeutic interventions. At Dr. Brennan's lab, she plans to acquire expertise in electrophysiology and two-photon imaging techniques to deepen her insights into the complex pathophysiology of migraine.